CLX: Leadership change · Company disclosure

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 14, 2026, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of The Clorox Company (the “Company”) appointed Chris Hyder, age 51, to be Executive Vice President and Chief Operating Officer (“COO”) effective June 17, 2026. Information on Mr. Hyder’s previous roles can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 filed with the SEC on August 8, 2025 (the “2025 10-K”) and is hereby incorporated into this Item 5.02. In connection with Mr. Hyder’s appointment, on June 14, 2026, the MDCC approved an increase in Mr. Hyder’s base salary to $800,000 and an increase in his short-term incentive target from 90% to 100% of his salary, effective as of June 17, 2026. In addition, on June 17, 2026, Mr. Hyder will receive a grant of restricted stock units that have an aggregate fair value of $4,000,000, which will vest in three years. Also on June 14, 2026, Nina Barton, formerly Executive Vice President and Group President – Care & Connection, was appointed Executive Vice President and Chief Growth & Strategy Officer, effective June 17, 2026. Information on Ms. Barton’s previous roles can be found in our 2025 10-K and is hereby incorporated into this Item 5.02. Neither Mr. Hyder nor Ms. Barton has any familial relationships nor related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K (17 CFR 229.401(d) and 229.404(a)) in connection with his or her appointment described above. Item 7.01 Regulation FD Disclosure. A copy of the press release announcing these developments is furnished as